Overview

The meetings gather innovative pharmaceutical CEOs to discuss pressing global health challenges and how the industry can contribute to shaping public health policy. Where possible, the BCR organizes meetings with government officials and policymakers.

Madrid: December 21, 2022

The Spanish Prime Minister, Pedro Sánchez, and the Ministers of Industry, Trade and Tourism, Reyes Maroto; Health, Carolina Darias; and Science and Innovation, Diana Morant, held a meeting on 21  December 2022 with over 20 presidents and top executives of pharmaceutical companies at global and national level, as well as with representatives of the sector’s trade associations, including IFPMA Director General Thomas Cueni and EFPIA Director General Nathalie Moll, with the objective of laying the foundations for a Strategic Plan to promote the development of the innovation pharmaceutical industry in Spain.

Read more

Berlin: June 20-21, 2022

CEOs met with officials from the German ministries of health and economic development as well as the Federal Chancellor’s office to discuss national and international developments that impact future innovation and global health.

They also discussed how the German government and industry can work together to reinvigorate innovation across the life sciences ecosystem.

Read more

London (virtual): December 2, 2021

CEOs met with the Prime Minister, senior UK Cabinet Ministers, and the NHS Chief Executive to discuss global health and innovation.

Discussions focused on how the industry and UK Government can work together to drive pharmaceutical innovation, rapidly deliver the next generation of medicines to patients worldwide and realize the UK Government’s Life Sciences Vision.

Read more

Brussels: June 21-22, 2021

CEOs discussed global health challenges and public health policies impacting biomedical innovation.

Read more

Tokyo: June 3-4, 2019

CEOs from IFPMA, Pharmaceutical Researchers and Manufacturers of America (PhRMA), the Japan Pharmaceutical Association (JPMA), and the European Federation of Pharmaceutical Industries and Associations (EFPIA) handed a joint statement to Japanese Prime Minister Shinzo Abe.

It called for Japan to:

  • Accelerate efforts around universal health coverage, especially in developing countries
  • Support development in areas with no effective treatments, such as antimicrobial treatments, through partnerships, regulatory harmonization, and predictable and reasonable IP protection rules
  • Craft legal frameworks that facilitate the use of AI and big data.

PM Abe expressed the Japanese government’s resolve to promote innovation.

Initiatives supported by the BCR

AMR Action Fund

The AMR Action Fund, the largest private/public initiative in this field, launched in 2019 with USD 1 billion funding principally raised by innovative pharmaceutical companies that aims to bring 2-4 new antibiotics to patients by 2030.

Pandemic Preparedness – Berlin Declaration

Drawing from lessons learned from the global response to COVID-19, IFPMA launched the Berlin Declaration. This sets out an approach to more equitable pandemic preparedness and response based on collaboration, commitments, and contributions across the global health community.

Chief Ethics and Compliance Officers (CECO) Roundtable

The Chief Ethics and Compliance Officers (CECO) Roundtable, inaugurated in 2020, is a biannual IFPMA forum bringing together the most senior executive Ethics & Compliance officers of IFPMA’s global, research-based pharmaceutical member companies committed to advancing the global ethics and business integrity policy priorities of the biopharmaceutical industry.

The CECO Roundtable is a strategic advisory body, providing a unique global policy platform on the topic of Ethics and Integrity, thus reinforcing IFPMA’s voice on this matter and prioritizing industry engagement.

Top